Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel)
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 21 - 80 |
| Updated: | 11/11/2018 |
| Start Date: | May 12, 2017 |
| End Date: | April 15, 2021 |
This study is a prospective, phase 2 extension study of participants previously enrolled in
NTMT-01 and of participants enrolled in NTMT-02. This study is designed to evaluate long term
safety and efficacy of the NT-501 implant in participants previously enrolled in the NTMT-01
and NTMT-02 protocols.
NTMT-01 and of participants enrolled in NTMT-02. This study is designed to evaluate long term
safety and efficacy of the NT-501 implant in participants previously enrolled in the NTMT-01
and NTMT-02 protocols.
Inclusion Criteria:
- Previously enrolled in the NTMT-01 or NTMT-02 protocol and received the NT-501 implant
and/or underwent a Sham procedure
- Participant must be offered sufficient opportunity to review and to understand the
informed consent form, agree to the form's contents, and provide written informed
consent.
Exclusion Criteria:
- There are no Exclusion Criteria
We found this trial at
9
sites
Massachusetts Eye & Ear Infirmary Whether you see our physicians at Mass. Eye and Ear's...
Click here to add this to my saved trials
Click here to add this to my saved trials
Atlanta, Georgia 30322
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Madison, Wisconsin 53705
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials